Sartorius 

€168.2
0
+€1+0.6% Friday 16:46

Statistics

Day High
173.4
Day Low
166.4
52W High
204
52W Low
144
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23AprExpected
Q4 2025
Next
1.25
1.27
1.29
1.3
Expected EPS
1.268705182737824
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SRT.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific offers a broad range of products and services in the life sciences sector, directly competing with Sartorius in areas such as lab equipment and bioprocessing technologies.
Danaher
DHR
Mkt Cap135.26B
Danaher Corporation operates in the life sciences, diagnostics, and environmental industries, competing with Sartorius in the bioprocessing and laboratory equipment sectors.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories provides products and services in the life science research and clinical diagnostics markets, competing with Sartorius in laboratory instruments and consumables.
Agilent Technologies
A
Mkt Cap32.66B
Agilent Technologies is a leader in life sciences, diagnostics, and applied chemical markets, offering analytical instruments that compete with Sartorius' lab products.
Waters
WAT
Mkt Cap29.85B
Waters Corporation specializes in analytical instruments for the life sciences sector, competing with Sartorius in the provision of lab equipment and supplies.
Bruker
BRKR
Mkt Cap5.6B
Bruker Corporation offers scientific instruments and analytical and diagnostic solutions, competing with Sartorius in the life science research and diagnostics sectors.
Mettler-Toledo International
MTD
Mkt Cap25.61B
Mettler-Toledo International is a provider of precision instruments and services, competing with Sartorius in the laboratory equipment and analytical instruments sector.
Repligen
RGEN
Mkt Cap6.59B
Repligen Corporation provides bioprocessing technologies and solutions, directly competing with Sartorius in the biotechnology and pharmaceutical manufacturing sectors.
Illumina
ILMN
Mkt Cap19.48B
Illumina, Inc. specializes in sequencing and array-based solutions for genetic analysis, indirectly competing with Sartorius in the broader life sciences market by offering complementary technologies for research.

About

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Show more...
CEO
Dr. Joachim Kreuzburg
Employees
16038
Country
DE
ISIN
DE0007165607

Listings

0 Comments

Share your thoughts

FAQ

What is Sartorius stock price today?
The current price of SRT.STU is €168.2 EUR — it has increased by +0.6% in the past 24 hours. Watch Sartorius stock price performance more closely on the chart.
What is Sartorius stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sartorius stocks are traded under the ticker SRT.STU.
Is Sartorius stock price growing?
SRT.STU stock has risen by +0% compared to the previous week, the month change is a -1.41% fall, over the last year Sartorius has showed a +9.36% increase.
When is the next Sartorius earnings date?
Sartorius is going to release the next earnings report on April 23, 2026.
What were Sartorius earnings last quarter?
SRT.STU earnings for the last quarter are 1.25 EUR per share, whereas the estimation was 1.3 EUR resulting in a -3.96% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Sartorius have?
As of April 11, 2026, the company has 16,038 employees.
In which sector is Sartorius located?
Sartorius operates in the Healthcare sector.
When did Sartorius complete a stock split?
Sartorius has not had any recent stock splits.
Where is Sartorius headquartered?
Sartorius is headquartered in Göttingen, DE.